Osteoanabolics
- PMID: 22629498
- PMCID: PMC3354839
- DOI: 10.4103/2230-8210.95662
Osteoanabolics
Abstract
Osteoporosis is characterized by reduced bone mass, impaired bone quality, and a propensity to fracture. An "osteoanabolic" should be referred to any therapy that helps increase bone mass. Bone mass represents 80% of bone mechanical strength. A low bone mass therefore provides the strongest association of future risk of fracture. This review aims to discuss all available and future therapies that attempt to increase bone mass be it organic or inorganic.
Keywords: Bone remodeling; osteo-anabolics; osteoporosis; teriparatide.
Conflict of interest statement
Figures
Similar articles
-
Osteoanabolic therapy for osteoporosis in women.Climacteric. 2022 Feb;25(1):60-66. doi: 10.1080/13697137.2021.1953463. Epub 2021 Aug 3. Climacteric. 2022. PMID: 34342243 Review.
-
Advances in Osteoporosis Therapy: Focus on Osteoanabolic Agents, Secondary Fracture Prevention, and Perioperative Bone Health.Curr Osteoporos Rep. 2023 Aug;21(4):386-400. doi: 10.1007/s11914-023-00793-8. Epub 2023 Jun 8. Curr Osteoporos Rep. 2023. PMID: 37289382 Free PMC article. Review.
-
[Use of osteoanabolics in fracture nonunion].Orthopade. 2015 Sep;44(9):710-715. doi: 10.1007/s00132-015-3145-5. Orthopade. 2015. PMID: 26205360 Review. German.
-
The role of osteoanabolic agents in the management of patients with osteoporosis.Postgrad Med. 2022 Aug;134(6):541-551. doi: 10.1080/00325481.2022.2069582. Epub 2022 May 30. Postgrad Med. 2022. PMID: 35635798 Review.
-
Osteoanabolic Agents for Osteoporosis.J Endocr Soc. 2018 Jul 9;2(8):922-932. doi: 10.1210/js.2018-00118. eCollection 2018 Aug 1. J Endocr Soc. 2018. PMID: 30087947 Free PMC article. Review.
Cited by
-
Primary hyperparathyroidism associated with vitamin D toxicity in a patient with severe osteoporosis receiving teriparatide.Indian J Endocrinol Metab. 2012 Sep;16(5):863-4. doi: 10.4103/2230-8210.100697. Indian J Endocrinol Metab. 2012. PMID: 23087890 Free PMC article. No abstract available.
-
Osteogenic ability using porous hydroxyapatite scaffold-based delivery of human placenta-derived mesenchymal stem cells.Exp Ther Med. 2021 Oct;22(4):1091. doi: 10.3892/etm.2021.10525. Epub 2021 Aug 2. Exp Ther Med. 2021. PMID: 34504545 Free PMC article.
-
Radiation Therapy in the Management of Head and Neck Mucosal Melanoma.Cancers (Basel). 2024 Sep 27;16(19):3304. doi: 10.3390/cancers16193304. Cancers (Basel). 2024. PMID: 39409922 Free PMC article. Review.
References
-
- Hadjidakis DJ, Androulakisii Bone remodeling. Ann N Y Acad Sci. 2006;1092:385–96. - PubMed
-
- Lemming DJ, Alexanderson P, Karsdal MA, Qvist P, Schaller S, Tankó LB. An update on biomarkers of bone turnover and their utility in biomedical research and clinical practise. Eur J Clin Pharmacol. 2006;62:781–92. - PubMed
-
- Seeman E, Delmas PD. Bone quality: The material and structural basis of bone strength and fragility. N Engl J Med. 2006;354:2250–61. - PubMed
-
- Schapira D, Schapira C. Osteoporosis: The evolution of a scientific term. Osteoporosis Int. 1992;4:164–7. - PubMed
-
- Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, et al. Risk fractures for hip fractures in white women. N Engl J Med. 1995;332:767–73. - PubMed